Revenio Group Corporation has published Annual Report and Report by the Board of Directors and Financial Statements of 2019
Revenio Group Corporation, Stock Exchange Release, February 26, 2020 at 12.00
Revenio Group Corporation has published Annual Report, Report by the Board of Directors and Financial Statements, Corporate Governance Statement, Remuneration Statement and Remuneration Policy of 2019
Revenio Group Corporation has published Annual Report, Report by the Board of Directors and Financial Statements of 2019 in company’s internet pages, in Finnish and English at:
https://www.reveniogroup.fi/sijoittajille/taloudelliset-raportit/ (Finnish)
https://www.reveniogroup.fi/en/investors/financial-reports/ (English)
The Annual Report contains a business review, which provides information on Revenio's business and operating environment. Report by the Board of Directors and Financial Statements of 2019 contains Report by the Board of Directors and Auditor's note.
A Corporate Governance Statement 2019 has also been published at:
https://www.reveniogroup.fi/sites/default/files/2020-02/Revenio_selvitys_hallinto_ja_ohjausjarjestelmasta_2019.pdf (in Finnish)
https://www.reveniogroup.fi/sites/default/files/2020-02/Revenio_corporate_governance_statement_2019.pdf (in English)
In addition, a separate Remuneration Statement of 2019 and Remuneration Policy 2019 has been published in Finnish and English at:
https://www.reveniogroup.fi/sites/default/files/2020-02/Revenio_palkka_ja_palkkioselvitys_2019.pdf (in Finnish)
https://www.reveniogroup.fi/sites/default/files/2020-02/Revenio_palkitsemispolitiikka_2019.pdf (in Finnish)
https://www.reveniogroup.fi/sites/default/files/2020-02/Revenio_salary_and_remuneration_report_2019.pdf (in English)
https://www.reveniogroup.fi/sites/default/files/2020-02/Revenio_remuneration_policy_2019.pdf (in English)
The Annual Report, Report by the Board of Directors and Financial Statements, Corporate Governance Statement as well as the Remuneration Statement are all pdf-attachments to this Stock Exchange Release.
Revenio does not publish a printed Annual Report.
REVENIO GROUP CORPORATION
For further information, please contact:
CEO and President Timo Hildén
tel. +358 40 580 4774
timo.hilden@revenio.fi
www.revenio.fi
DISTRIBUTION:
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi
Revenio Group in brief
Revenio, a health technology group operating in the international markets, is one of the global leaders in ophthalmic appliances.
The Revenio Group consists of Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, CenterVue Inc, Revenio Research Oy and Oscare Medical Oy.
The common denominators of Revenio's business operations include patient-oriented screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The aim is to improve the quality of life through health technology solutions which enable more effective diagnostics. Revenio Group’s focus is on the early detection of glaucoma, diabetic retinopathy and macular degeneration, and the monitoring of these during the treatment process. Revenio Research concentrates on the commercialization of systems supporting the diagnosis of and treatment planning for skin cancer and asthma.
In 2019, Revenio Group's net sales totalled EUR 49.5 million, with its net operating profit standing at 25.5%. Revenio Group Corporation is listed on Nasdaq Helsinki.